Sinus Dilation Devices Market

Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027

Report Code: MD 6372 Aug, 2022, by marketsandmarkets.com

The global sinus dilation devices market in terms of revenue was estimated to be worth $2.8 billion in 2022 and is poised to reach $3.8 billion by 2027, growing at a CAGR of 6.6% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The expansion of this market is due in large part to the upsurge in cases of chronic sinusitis as well as growing healthcare spending. However, a lack of skilled ENT professionals is one of the challenges that may inhibit the growth of this market.

Sinus Dilation Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Sinus Dilation Devices Market Dynamics

Driver: Up-surging Cases of Chronic Sinusitis

Sinusitis is a medical condition wherein the cavities around the nasal passages (sinuses) are inflamed or swollen for more than twelve weeks. Chronic sinusitis can be caused by an infection, growths in the sinuses (nasal polyps), or swelling of the lining of the sinuses. Nasal polyps affect an estimated 4–40% of the general population (Source: PubMed). Chronic sinusitis is one of the most common medical conditions and accounts for around USD 2.4 billion in annual healthcare costs (not including surgery or radiographic imaging) in the US (Source: NCBI 2022). According to Medscape 2022, sinusitis affects 1 out of every 7 adults in the United States, with more than 30 million individuals diagnosed each year. Similarly, rhinosinusitis affects an estimated 35 million people per year in the US and accounts for close to 16 million physician office visits per year. Like the US, chronic sinusitis is a highly prevalent condition in the UK and affects 10% of the adult population in the country (Source: NHS). According to the National Institute of Allergy and Infectious Diseases (NIAID), chronic sinusitis affects ~134 million people in India. Owing to the high prevalence of chronic sinusitis in several countries across the globe, the demand for various ENT treatments, such as endoscopic sinus surgeries, functional endoscopic sinus surgery (FESS), and balloon sinus dilation, is high. As a result, the high prevalence of chronic sinusitis is one of the major factors driving the growth of the global market.

Opportunity: Growing Healthcare Market in Emerging Economies..

Developing economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the global market. According to the OECD, the global middle-class population is estimated to increase from 1.8 billion in 2009 to 4.9 billion by 2030. Asia is expected to account for 66% of the global middle-class population by 2030. In countries such as China and India, the growth in purchasing power is enabling people to opt for technologically advanced ENT treatments, including sinus dilation, thereby fuelling the growth of the market.

Due to the presence of a large target patient population, these countries offer sinus dilation device manufacturers potential opportunities to expand their reach outside the US. The Asia Pacific market is considered a major growth market for sinus dilation devices. Factors such as less stringent regulatory policies and improving healthcare facilities in these countries are expected to create potential growth opportunities for market players in the coming years.

Challenge: Survival of Small Players And New Entrants

The global market is a capital-intensive market. Significant R&D investments are needed to ensure innovation in product offerings to cater to the changing needs of the customers. In this market, there are several well-established players that have successfully built a strong image, which makes it difficult for the new entrants to compete with them. Furthermore, lack of economies of scale, moderate market growth, and high manufacturing cost of devices are some of the challenges faced by start-ups and niche market players, at least in the initial years.

China is anticipated to account the largest share of APAC sinus dilation devices market

Based on the Apac region, the market is divided into China, Japan, and India. China is expected to account the largest share of this market., the growing investment in medical device sector due to rising geriatric population, technological improvement, and the development of clinic and hospital service are the key factor driving market growth in China.

UK is forecasted as the fastest growing region of sinus dilation devices market in Europe

Based on the Europe region, the market is divided into Germany, UK, Italy, Spain, France, and RoE. UK is forecasted to the fastest growing market of sinus dilation devices in Europe the government initiatives to improve the awareness in the field of otolaryngology and the high prevalence of chronic rhinosinusitis are the crucial factor thriving the market growth in UK.

Standalone sinus dilation procedure in the procedure segment of sinus dilation devices market to witness the highest shares during the forecast period.

Based on the procedure, the market is classified into Standalone sinus dilation procedure and hybrid sinus dilation procedure. The Standalone sinus dilation procedure segment is expected to dominate because of its wider advantages such as fewer post procedural debridement episodes as opposed to FESS, reduced postoperative nasal bleeding, shorter recovery as well as medication for pain relief, and short-term symptom improvement. These are the key factors driving the growth of the Standalone sinus dilation procedure in the market.

North America dominates the global sinus dilation devices market

Based on the region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global market. Growth in the North American market is mainly driven by rising healthcare spending, increasing cases of chronic sinusitis and availability of favourable healthcare reforms such as the Affordable Care Act and Medicare.

Sinus Dilation Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the players operating in the sinus dilation devices market are Acclarent, inc. (a subsidiary of Johnson & Johnson) (US), Entellus Medical Inc. (A Subsidiary of Stryker) (US), Intersect ENT, Inc. (US), SinuSys Corporation (US), Optim LLC (US), Sklar Surgical Instruments (US), Dalent Medical (US), Summit Medical LLC. (US), and Cook Medical (US)

Sinus Dilation Devices Market Report Scope

Report Metrics

Details

Market Revenue in 2022

$2.8 billion

Projected Revenue by 2027

$3.8 billion

Revenue Rate

Poised to grow at a CAGR of 6.6%

Market Segmentation

By Product, Procedure, Patient Type, Patient Care Setting and Region

Market Driver

Upsurging Cases of Chronic Sinusitis

This research report categorizes the sinus dilation devices market to forecast revenue and analyze trends in each of the following submarkets

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Product

  • Balloon sinus dilation devices
  • Endoscopes
    • Sinuscopes
    • Rhinoscopes
  • Sinus stents/implants
  • Handheld instruments

By Patient Type

  • Adult
    • Pediatric

By Procedure

  • Standalone sinus dilation procedures
  • Hybrid sinus dilation procedures

By Patient Care Setting

  • Hospitals and ambulatory surgery centers (ASCs)
  • ENT clinics

Recent Developments

  • In 2021, Intersect ENT (US) announced the launch of the new Straight Delivery System packaged with the PROPEL Mini Sinus Implant
  • In 2019, XION GmbH (Germany) launched the stroboscopy-capable Spectar XN P pediatric video nasopharyngoscope and 2.7 mm thin 3D endoscopes for ENT applications

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 GEOGRAPHIC SCOPE
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION FOR JOHNSON & JOHNSON
          FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
          FIGURE 7 MARKET SIZE ESTIMATION FROM PARENT MARKET
           2.2.1 GROWTH FORECAST
                    FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 9 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS
    2.5 STUDY ASSUMPTIONS
    2.6 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 11 SINUS DILATION DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 ENDOSCOPES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 MARKET, BY PATIENT TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 MARKET, BY PATIENT CARE SETTING, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 MARKET, BY PROCEDURE, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 GEOGRAPHIC SNAPSHOT OF GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 SINUS DILATION DEVICES MARKET OVERVIEW
          FIGURE 17 HIGH PREVALENCE OF CHRONIC SINUSITIS TO DRIVE MARKET
    4.2 MARKET, BY PATIENT CARE SETTING, 2022–2027
          FIGURE 18 HOSPITALS AND ASCS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.3 ASIA PACIFIC: MARKET, BY PRODUCT AND COUNTRY (2022)
          FIGURE 19 BALLOON SINUS DILATION DEVICES SEGMENT TO DOMINATE ASIA PACIFIC MARKET IN 2022
    4.4 GEOGRAPHIC SNAPSHOT OF MARKET
          FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 21 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 High prevalence of chronic sinusitis
                    5.2.1.2 Benefits of balloon dilation procedures over traditional endoscopic sinus surgeries
                    5.2.1.3 Growing preference for minimally invasive surgeries
                    5.2.1.4 Rising healthcare expenditure
                                FIGURE 22 CURRENT HEALTH EXPENDITURE PER CAPITA
                    FIGURE 23 CURRENT HEALTH EXPENDITURE (% OF GDP)
                    5.2.1.5 Increasing availability of reimbursements
           5.2.2 RESTRAINTS
                    5.2.2.1 Risks associated with sinus surgeries
                    5.2.2.2 Availability of non-surgical treatments for chronic sinusitis
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare market in emerging economies
                                FIGURE 24 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRIC COUNTRIES, 2012–2019
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled otolaryngologists, ENT surgeons, and endoscopists
                    5.2.4.2 Survival of small players and new entrants
    5.3 RANGES/SCENARIOS
          FIGURE 25 PESSIMISTIC SCENARIO
          FIGURE 26 OPTIMISTIC SCENARIO
          FIGURE 27 REALISTIC SCENARIO
    5.4 VALUE CHAIN ANALYSIS
          FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
    5.5 SUPPLY CHAIN ANALYSIS
          FIGURE 29 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.6 TECHNOLOGY ANALYSIS
          TABLE 2 BENEFITS OF ENDOSCOPIC PROCEDURE
    5.7 PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 INTENSITY OF COMPETITIVE RIVALRY
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 THREAT OF SUBSTITUTES
    5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
                    TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
           5.8.2 BUYING CRITERIA
                    FIGURE 31 KEY BUYING CRITERIA FOR END USERS
                    TABLE 4 KEY BUYING CRITERIA FOR END USERS
    5.9 REGULATORY LANDSCAPE
          TABLE 5 REGULATORY AUTHORITIES GOVERNING GLOBAL MARKET
    5.10 PATENT ANALYSIS
    5.11 KEY CONFERENCES AND EVENTS
           TABLE 6 LIST OF CONFERENCES AND EVENTS, 2022–2023
    5.12 PRICING ANALYSIS
           TABLE 7 PRICE RANGE FOR SINUS DILATION DEVICES
    5.13 TRADE ANALYSIS
           TABLE 8 NUMBER OF EXPORTS AND IMPORTS RELATED TO ENDOSCOPY EQUIPMENT
    5.14 ECOSYSTEM ANALYSIS
           TABLE 9 ROLE IN ECOSYSTEM
           FIGURE 32 KEY PLAYERS OPERATING IN GLOBAL MARKET
    5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

6 SINUS DILATION DEVICES MARKET, BY PRODUCT (Page No. - 82)
    6.1 INTRODUCTION
          TABLE 10 MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 BALLOON SINUS DILATION DEVICES
           6.2.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO SUPPORT MARKET
                    TABLE 11 BALLOON MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 ENDOSCOPES
          TABLE 12 ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 13 ENDOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.1 SINUSCOPES
                    6.3.1.1 Largest and fastest-growing segment of endoscopes market
                                TABLE 14 SINUSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 RHINOSCOPES
                    6.3.2.1 Primarily used to examine nasal cavity and passage
                                TABLE 15 RHINOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 SINUS STENTS/IMPLANTS
           6.4.1 SINUS STENTS/IMPLANTS ARE USED POSTOPERATIVELY FOLLOWING AN ENDOSCOPIC SINUS SURGERY
                    TABLE 16 SINUS STENTS/IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.5 HANDHELD INSTRUMENTS
           6.5.1 HANDHELD INSTRUMENTS ARE WIDELY USED IN ALMOST ALL KINDS OF SURGERIES
                    TABLE 17 HANDHELD INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)

7 SINUS DILATION DEVICES MARKET, BY PROCEDURE (Page No. - 90)
    7.1 INTRODUCTION
          TABLE 18 MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
    7.2 STANDALONE SINUS DILATION PROCEDURES
           7.2.1 STANDALONE SINUS DILATION PROCEDURES ARE WIDELY USED FOR SINUS DILATION
                    TABLE 19 STANDALONE SINUS DILATION PROCEDURES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 HYBRID SINUS DILATION PROCEDURES
           7.3.1 HYBRID SINUS DILATION PROCEDURES ARE MORE INVASIVE IN NATURE COMPARED TO STANDALONE PROCEDURES
                    TABLE 20 NUMBER OF SINUS PROCEDURES PERFORMED IN ENGLAND BETWEEN 2010 AND 2019
                    TABLE 21 HYBRID SINUS DILATION PROCEDURES MARKET, BY REGION, 2020–2027 (USD MILLION)

8 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE (Page No. - 94)
    8.1 INTRODUCTION
          TABLE 22 MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
    8.2 ADULT PATIENTS
           8.2.1 ADULT PATIENTS DOMINATE MARKET
                    FIGURE 33 THE PERCENTAGE DISTRIBUTION OF CHRONIC SINUSITIS BY AGE GROUP.
                    TABLE 23 ADULT MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.3 PEDIATRIC PATIENTS
           8.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
                    FIGURE 34 TIME OF ONSET OF CRS TO THE FIRST SURGICAL INTERVENTION FOR ENDOSCOPIC SINUS SURGERY PATIENTS.
                    TABLE 24 PEDIATRIC MARKET, BY REGION, 2020–2027 (USD MILLION)

9 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING (Page No. - 99)
    9.1 INTRODUCTION
          TABLE 25 MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
    9.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
           9.2.1 LARGEST AND FASTEST-GROWING END USERS OF SINUS DILATION DEVICES
                    TABLE 26 MARKET FOR HOSPITALS AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)
    9.3 ENT CLINICS
           9.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS ARE SUPPORTING SEGMENT GROWTH
                    TABLE 27 MARKET FOR ENT CLINICS, BY REGION, 2020–2027 (USD MILLION)

10 SINUS DILATION DEVICES MARKET, BY REGION (Page No. - 102)
     10.1 INTRODUCTION
             TABLE 28 MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 35 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 29 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 30 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 31 NORTH AMERICA: MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 32 NORTH AMERICA: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 33 NORTH AMERICA: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 34 NORTH AMERICA: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Favorable reimbursement scenario for sinus dilation procedures
                                      TABLE 35 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 36 US: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 37 US: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
                                      TABLE 38 CANADA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 39 CANADA: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 40 CANADA: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 41 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 42 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 43 EUROPE: MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 44 EUROPE: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 45 EUROPE: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 46 EUROPE: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Rising geriatric population and increasing R&D—key factors driving market
                                      TABLE 47 GERMANY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 48 GERMANY: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 49 GERMANY: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Fastest-growing market for sinus dilation devices in Europe
                                      TABLE 50 UK: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 51 UK: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 52 UK: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 High burden of chronic sinusitis to drive market
                                      TABLE 53 FRANCE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 54 FRANCE: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 55 FRANCE: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Growing geriatric population to support adoption of sinus dilation devices
                                      TABLE 56 ITALY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 57 ITALY: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 58 ITALY: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Rising healthcare expenditure to support market for sinus dilation devices
                                      TABLE 59 SPAIN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 60 SPAIN: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 61 SPAIN: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 62 REST OF EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 63 REST OF EUROPE: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                        TABLE 64 REST OF EUROPE: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 36 ASIA PACIFIC: MARKET SNAPSHOT
             TABLE 65 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 66 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 67 ASIA PACIFIC: MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 68 ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 69 ASIA PACIFIC: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 70 ASIA PACIFIC: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Fastest-growing market for sinus dilation devices
                                      TABLE 71 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 72 CHINA: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 73 CHINA: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Large geriatric population to aid market growth
                                      TABLE 74 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 75 JAPAN: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 76 JAPAN: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 High prevalence of sinusitis will drive demand for sinus dilation devices
                                      TABLE 77 INDIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 78 INDIA: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 79 INDIA: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 80 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 81 REST OF ASIA PACIFIC: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                        TABLE 82 REST OF ASIA PACIFIC: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
     10.5 REST OF THE WORLD
             TABLE 83 REST OF THE WORLD: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 84 REST OF THE WORLD: MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 85 REST OF THE WORLD: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 86 REST OF THE WORLD: MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 87 REST OF THE WORLD: MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 131)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             TABLE 88 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINUS DILATION MARKET
     11.3 REVENUE SHARE ANALYSIS
             FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINUS DILATION MARKET
     11.4 MARKET SHARE ANALYSIS
             TABLE 89 MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 38 COMPANY EVALUATION QUADRANT: SINUS DILATION MARKET
     11.6 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 39 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS: SINUS DILATION MARKET
     11.7 COMPANY FOOTPRINT ANALYSIS
             TABLE 90 FOOTPRINT OF COMPANIES IN SINUS DILATION MARKET
             TABLE 91 REGIONAL FOOTPRINT OF COMPANIES
             TABLE 92 PRODUCT FOOTPRINT OF COMPANIES
     11.8 COMPETITIVE BENCHMARKING
             TABLE 93 SINUS DILATION MARKET: LIST OF KEY STARTUPS/SMES
     11.9 COMPETITIVE SCENARIO
             11.9.1 PRODUCT LAUNCHES/APPROVALS
                        TABLE 94 KEY PRODUCT LAUNCHES
             11.9.2 DEALS
                        TABLE 95 KEY DEALS
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 96 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 148)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 ENTELLUS MEDICAL, INC. (SUBSIDIARY OF STRYKER)
                        TABLE 97 STRYKER: BUSINESS OVERVIEW
                        FIGURE 40 STRYKER: COMPANY SNAPSHOT (2021)
             12.1.2 MEDTRONIC PLC
                        TABLE 98 MEDTRONIC PLC: BUSINESS OVERVIEW
                        FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
             12.1.3 ACCLARENT, INC. (SUBSIDIARY OF JOHNSON & JOHNSON)
                        TABLE 99 JOHNSON & JOHNSON: BUSINESS OVERVIEW
                        FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
             12.1.4 SMITH & NEPHEW PLC
                        TABLE 100 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
                        FIGURE 43 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
             12.1.5 INTERSECT ENT, INC.
                        TABLE 101 INTERSECT ENT, INC.: BUSINESS OVERVIEW
                        FIGURE 44 INTERSECT ENT, INC.: COMPANY SNAPSHOT (2021)
             12.1.6 OLYMPUS CORPORATION
                        TABLE 102 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.7 SINUSYS CORPORATION
                        TABLE 103 SINUSYS CORPORATION: BUSINESS OVERVIEW
             12.1.8 INNACCEL TECHNOLOGIES PVT LTD.
                        TABLE 104 INNACCEL TECHNOLOGIES PVT LTD.: BUSINESS OVERVIEW
             12.1.9 MERIL LIFE SCIENCES PVT. LTD.
                        TABLE 105 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
             12.1.10 OPTIM LLC
                        TABLE 106 OPTIM LLC: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS
             12.2.1 JILIN CORONADO MEDICAL LTD.
                        TABLE 107 JILIN CORONADO MEDICAL LTD.: BUSINESS OVERVIEW
             12.2.2 DALENT MEDICAL
                        TABLE 108 DALENT MEDICAL: BUSINESS OVERVIEW
             12.2.3 EMOS TECHNOLOGY GMBH
                        TABLE 109 EMOS TECHNOLOGY GMBH: BUSINESS OVERVIEW
             12.2.4 SKLAR SURGICAL INSTRUMENTS
                        TABLE 110 SKLAR SURGICAL INSTRUMENTS: BUSINESS OVERVIEW
             12.2.5 KARL STORZ
                        TABLE 111 KARL STORZ: BUSINESS OVERVIEW
             12.2.6 PENTAX MEDICAL
                        TABLE 112 PENTAX MEDICAL: BUSINESS OVERVIEW
             12.2.7 ANGIPLAST PVT. LTD.
                        TABLE 113 ANGIPLAST PVT. LTD.: BUSINESS OVERVIEW
             12.2.8 SUMMIT MEDICAL LLC
                        TABLE 114 SUMMIT MEDICAL LLC: BUSINESS OVERVIEW
             12.2.9 RICHARD WOLF GMBH
                        TABLE 115 RICHARD WOLF GMBH: BUSINESS OVERVIEW
             12.2.10 ENTERMED
                        TABLE 116 ENTERMED: BUSINESS OVERVIEW
             12.2.11 SCHÖLLY FIBEROPTIC GMBH
                        TABLE 117 SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW
             12.2.12 XION GMBH
                        TABLE 118 XION GMBH: BUSINESS OVERVIEW
             12.2.13 COOK MEDICAL
                        TABLE 119 COOK MEDICAL: BUSINESS OVERVIEW
             12.2.14 MAXER ENDOSCOPY GMBH
                        TABLE 120 MAXER ENDOSCOPY GMBH: BUSINESS OVERVIEW
             12.2.15 ESC MEDICAMS
                        TABLE 121 ESC MEDICAMS: BUSINESS OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 192)
     13.1 INDUSTRY INSIGHTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 CUSTOMIZATION OPTIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the sinus dilation devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons) and supply sides (sinus dilation device manufacturers and distributors).

The following is a breakdown of the primary respondents:

Sinus Dilation Devices Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sinus dilation devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the sinus dilation devices industry.

Report Objectives

  • To define, describe, and forecast the global sinus dilation devices market based on product, procedure, Patient type, Patient care setting, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the sinus dilation devices market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis: Further breakdown of the European sinus dilation devices market into specific countries.  
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 6372
Published ON
Aug, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sinus Dilation Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback